Clinical Trial

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Name: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia — clinical trial record (NCT07114874)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

Protocol Amendment History 1 change

notable Enrollment reduced: 800 -> 600 participants 2026-05-16

Trial Details

NCT Number	NCT07114874
Lead Sponsor	Neurocrine Biosciences
Conditions	Schizophrenia
Enrollment	600 participants
Start Date	2025-07-11
Primary Completion	2031-12 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-05